Literature DB >> 30110182

Impact of Cigarette Smoke Exposure on the Lung Fibroblastic Response after Influenza Pneumonia.

Sei Won Lee1,2,3, Lokesh Sharma1, Young Ae Kang1,4, Sang-Hun Kim1, Sreelakshmi Chandrasekharan1, Ashley Losier1, Virginia Brady1, Santos Bermejo1, Nathaniel Andrews1, Chang-Min Yoon1, Wei Liu1, Jung-Yeon Lee1,5, Min-Jong Kang1, Charles S Dela Cruz1.   

Abstract

Influenza viruses can result in significant lung injury with significant morbidity and mortality. In this study, we evaluated the impact of cigarette smoke (CS) exposure on the pulmonary fibroblastic response after influenza infection. We used a murine model in which animals were exposed to CS or room air and subsequently infected with H1N1 influenza virus. Inflammatory and fibrotic responses were measured at different time points after influenza infection. Primary fibroblasts were isolated from the lungs of mice and their characteristics were evaluated. Exposure to CS significantly increased the amount of collagen in the lungs of mice infected with influenza virus compared with the nonsmoking group at 30 days after infection. Furthermore, the presence of fibroblast-specific protein-positive cells increased in the lungs of influenza-infected mice that were exposed to CS compared with the infection-alone group. The smoking group also showed delays in weight recovery and higher cell counts in BAL fluid after infection. Active transforming growth factor β1 levels in BAL fluid increased in both groups; however, CS-exposed mice had a later surge in active transforming growth factor β1 (Day 24). Ex vivo cultures of lung-derived fibroblasts from CS-exposed mice with influenza infection showed rapid proliferation, increased expression of α-smooth muscle actin-stained stress fibers, and higher expression of growth factors compared with fibroblasts from room air-exposed lungs after infection. These results suggest that CS exposure changes the fibroblastic potential, leading to increased fibrosis after influenza infection.

Entities:  

Keywords:  fibroblast; fibrosis; influenza virus; pneumonia; smoking

Mesh:

Year:  2018        PMID: 30110182      PMCID: PMC6293077          DOI: 10.1165/rcmb.2018-0004OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  40 in total

Review 1.  Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis.

Authors:  Harish Nair; W Abdullah Brooks; Mark Katz; Anna Roca; James A Berkley; Shabir A Madhi; James Mark Simmerman; Aubree Gordon; Masatoki Sato; Stephen Howie; Anand Krishnan; Maurice Ope; Kim A Lindblade; Phyllis Carosone-Link; Marilla Lucero; Walter Ochieng; Laurie Kamimoto; Erica Dueger; Niranjan Bhat; Sirenda Vong; Evropi Theodoratou; Malinee Chittaganpitch; Osaretin Chimah; Angel Balmaseda; Philippe Buchy; Eva Harris; Valerie Evans; Masahiko Katayose; Bharti Gaur; Cristina O'Callaghan-Gordo; Doli Goswami; Wences Arvelo; Marietjie Venter; Thomas Briese; Rafal Tokarz; Marc-Alain Widdowson; Anthony W Mounts; Robert F Breiman; Daniel R Feikin; Keith P Klugman; Sonja J Olsen; Bradford D Gessner; Peter F Wright; Igor Rudan; Shobha Broor; Eric A F Simões; Harry Campbell
Journal:  Lancet       Date:  2011-11-10       Impact factor: 79.321

2.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

3.  Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing.

Authors:  I Darby; O Skalli; G Gabbiani
Journal:  Lab Invest       Date:  1990-07       Impact factor: 5.662

4.  Persistent Pathology in Influenza-Infected Mouse Lungs.

Authors:  Cindy M Kanegai; Ying Xi; Matthew L Donne; Jeffrey E Gotts; Ian H Driver; Gorica Amidzic; Andrew J Lechner; Kirk D Jones; Andrew E Vaughan; Harold A Chapman; Jason R Rock
Journal:  Am J Respir Cell Mol Biol       Date:  2016-10       Impact factor: 6.914

5.  Smoking and epidemic influenza-like illness in female military recruits: a brief survey.

Authors:  J D Kark; M Lebiush
Journal:  Am J Public Health       Date:  1981-05       Impact factor: 9.308

6.  Inhibition of TGF-beta signaling exacerbates early cardiac dysfunction but prevents late remodeling after infarction.

Authors:  Masaki Ikeuchi; Hiroyuki Tsutsui; Tetsuya Shiomi; Hidenori Matsusaka; Shouji Matsushima; Jing Wen; Toru Kubota; Akira Takeshita
Journal:  Cardiovasc Res       Date:  2004-12-01       Impact factor: 10.787

7.  Pulmonary fibrosis correlates with outcome in adult respiratory distress syndrome. A study in mechanically ventilated patients.

Authors:  C Martin; L Papazian; M J Payan; P Saux; F Gouin
Journal:  Chest       Date:  1995-01       Impact factor: 9.410

8.  Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis.

Authors:  Chun Geun Lee; Dominik Hartl; Gap Ryol Lee; Barbara Koller; Hiroshi Matsuura; Carla A Da Silva; Myung Hyun Sohn; Lauren Cohn; Robert J Homer; Alexander A Kozhich; Alison Humbles; Jennifer Kearley; Anthony Coyle; Geoffrey Chupp; Jennifer Reed; Richard A Flavell; Jack A Elias
Journal:  J Exp Med       Date:  2009-05-04       Impact factor: 14.307

9.  Cigarette smoke worsens lung inflammation and impairs resolution of influenza infection in mice.

Authors:  Rosa C Gualano; Michelle J Hansen; Ross Vlahos; Jessica E Jones; Ruth A Park-Jones; Georgia Deliyannis; Stephen J Turner; Karen A Duca; Gary P Anderson
Journal:  Respir Res       Date:  2008-07-15

10.  Epithelial-derived TGF-β1 acts as a pro-viral factor in the lung during influenza A infection.

Authors:  L Denney; W Branchett; L G Gregory; R A Oliver; C M Lloyd
Journal:  Mucosal Immunol       Date:  2017-10-25       Impact factor: 7.313

View more
  7 in total

1.  USP13 Deficiency Aggravates Cigarette-smoke-induced Alveolar Space Enlargement.

Authors:  Alyssa D Gregory; Kevin C Tran; Arya S Tamaskar; Jianxin Wei; Jing Zhao; Yutong Zhao
Journal:  Cell Biochem Biophys       Date:  2021-05-25       Impact factor: 2.194

2.  PINK1 Inhibits Multimeric Aggregation and Signaling of MAVS and MAVS-Dependent Lung Pathology.

Authors:  Sang-Hun Kim; Hyeon Jun Shin; Chang Min Yoon; Sei Won Lee; Lokesh Sharma; Charles S Dela Cruz; Min-Jong Kang
Journal:  Am J Respir Cell Mol Biol       Date:  2021-05       Impact factor: 6.914

Review 3.  Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract.

Authors:  Tim Flerlage; David F Boyd; Victoria Meliopoulos; Paul G Thomas; Stacey Schultz-Cherry
Journal:  Nat Rev Microbiol       Date:  2021-04-06       Impact factor: 78.297

Review 4.  Abnormal respiratory progenitors in fibrotic lung injury.

Authors:  Ting Xie; Heather Lynn; William C Parks; Barry Stripp; Peter Chen; Dianhua Jiang; Paul W Noble
Journal:  Stem Cell Res Ther       Date:  2022-02-07       Impact factor: 6.832

Review 5.  In Vivo and In Vitro Studies of Cigarette Smoke Effects on Innate Responses to Influenza Virus: A Matter of Models?

Authors:  Wenxin Wu; Jeremy S Alexander; Jordan P Metcalf
Journal:  Viruses       Date:  2022-08-20       Impact factor: 5.818

6.  Secular trends and determinants of influenza vaccination uptake among patients with cardiovascular disease in Korea: Analysis using a nationwide database.

Authors:  Min Kim; Bumhee Yang; Seonhye Gu; Eung-Gook Kim; So Rae Kim; Kyeong Seok Oh; Woong-Su Yoon; Dae-Hwan Bae; Ju Hee Lee; Sang Min Kim; Woong Gil Choi; Jang-Whan Bae; Kyung-Kuk Hwang; Dong-Woon Kim; Myeong-Chan Cho; Hyun Lee; Dae-In Lee
Journal:  Front Cardiovasc Med       Date:  2022-10-04

Review 7.  Effects of Cigarette Smoking on Influenza Virus/Host Interplay.

Authors:  Jerald Chavez; Rong Hai
Journal:  Pathogens       Date:  2021-12-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.